Fact CheckerSign in

NCT07488156Not yet recruiting

Improving Health Literacy in Patients With Schizophrenia Spectrum Disorder

The Impact of Health Literacy on the Attitudes Toward Pharmacological Treatment in Patients With Schizophrenia Spectrum Disorder

Source: ClinicalTrials.gov · Last updated 23 Mar 2026

Brief summary (registry, in English)

The Impact of Health Literacy on the Attitudes toward Pharmacological Treatment in Patients with Schizophrenia Spectrum Disorder This interventional study is aimed at: * assessing and improving the health literacy and * assessing the attitude towards treatment of patients with schizophrenia spectrum disorders while they are admitted to the inpatient psychiatric unit.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
34 (estimated)
First submitted
7 Nov 2025
Start date
1 Mar 2026
Primary completion date
30 Jul 2027
Lead sponsor
Louisiana State University Health Sciences Center in New Orleans
NCT number
NCT07488156

What you commit to

  • Study type: Interventional
  • Planned participants: 34
  • From 1 Mar 2026 to the primary completion date, 30 Jul 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients with SSD and concomitant intellectual disability, as evidenced by prior documented history on chart review or patients suspected to have intellectual disability or impairment based on clinical interactions
  • Patients with concomitant substance use and documentation of psychosis being resolved after a period of washout and without the use of psychotropic medications

Age

  • Patients at UMCNO that are ages 17 or younger

Other

  • Patients unable to complete health literacy assessments, attitude towards treatment assessments, and IQ testing due to severity of symptoms during hospitalization
  • Patients that are not proficient in English
  • Patients that do not have a government issued social security number

Who the study is looking for

  • Patients admitted to the University Medical Center-New Orleans (UMCNO) inpatient behavioral health unit ages 18 and older with a new or previous diagnosis of schizophrenia spectrum disorder outside of substance use disorders
  • Patients must be proficient in English.
  • Patients must have a government issued social security number (required for reimbursement through the university).

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Medical Center
Coordinator of this site? Confirm its status
New OrleansUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.